A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-Risk Early-Stage Breast Cancer - (LoTam)
A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-Risk Early-Stage Breast Cancer - (LoTam)
Protocol#: A012301
Contact
Clinical Trials Office at [email protected] or (203) 358-8879.
Principal Investigator(s)
Steve Lo, MD
Sponsor(s)
Alliance for Clinical Trials in Oncology
Location
Bennett Cancer Center
One Hospital Plaza
Stamford, CT 06902
Main: 203-358-8879
Stamford, CT 06902
Main: 203-358-8879